Sort
82,697 grants matching “vaccine development”
Multiscale modeling of influenza vaccination strategies for optimal T cell immunity
$681,224Jacob E Kohlmeier · Emory University · U01 · FY2021 · HL
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
$681,214Steven Edward Bosinger · Emory University · U24 · FY2020 · AI
Developing a dynamic modeling framework for surveillance, prediction, and real-time resource allocation to reduce health disparities during Covid-19 and future pandemics
$681,194Lior Rennert · Clemson University · R01 · FY2023 · LM
Prodrugs of Neuraminidase Inhibitors for Increased Oral Bioavailability
$681,168John M Hilfinger · Tsrl, Inc. · R44 · FY2011 · AI
Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein
$681,068Joseph G Sodroski · Dana-Farber Cancer Inst · R01 · FY2019 · AI
EIAV Envelope Variation and Vaccine Efficacy
$681,025Ronald C Montelaro · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus
$681,022Gregg A Dean · Colorado State University · R01 · FY2021 · AI
Centralized IIS-Based Reminder-Recall to Increase Influenza Vaccination Rates
$680,992Allison Kempe · University Of Colorado Denver · R01 · FY2017 · AI
Developmental Core
$680,925Elizabeth A Klonoff · San Diego State University · U54 · FY2008 · CA
Nanovaccine-Mediated Immune Protection Against Influenza Virus
$680,912Kevin L Legge · University Of Iowa · R01 · FY2021 · AI
Non-human primate core
$680,898Karen A Norris · Lsu Health Sciences Center · P01 · FY2012 · HL
Non-human primate core
$680,898Karen A Norris · Lsu Health Sciences Center · P01 · FY2015 · HL
Traineeship in AIDS Prevention Studies
$680,890Susan M. Kegeles · University Of California, San Francisco · T32 · FY2006 · MH
Anti-viral IL6 approach to mitigate KSHV-related disease
$680,879Scott W Wong · Oregon Health & Science University · R01 · FY2009 · CA
CONTROLLED RELEASE POLYMERS FOR BRAIN TUMORS (U19 CA 528
$680,849Johns Hopkins University · U19 · FY2000 · CA
Analyses of human T regulatory cells
$680,834Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Identification of human tumor-associated antigens
$680,834Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever
$680,797Jinhong Chang · Baruch S. Blumberg Institute · R01 · FY2022 · AI
Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies
$680,752John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
Malaria Pathogenesis and Clinical Immunity
$680,683Thomas E Wellems · Niaid Extramural Activities · Z01 · FY2007 · AI
Molecular Analysis of Host Immune Response in Leprosy
$680,666Robert L Modlin · University Of California Los Angeles · R01 · FY2019 · AI
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
$680,609Colleen F Kelley · Emory University · R01 · FY2022 · AI
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine
$680,601Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2024 · AI
COVID-19 Sample Collection and Vaccine Studies
$680,544Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Mechanistic Analysis of Zika Virus Induced Placental Damage During Pregnancy
$680,493Daniel N Streblow · Oregon Health & Science University · R01 · FY2021 · HD